Clinical Trial Update: Evaluating the Efficacy and Safety of Metformin in Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin for vitiligo has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Vitiligo | Phase 2 | Status: WITHDRAWN